Bimekizumab versus Secukinumab in Plaque Psoriasis

Kristian Reich; Richard B. Warren; Mark Lebwohl; Melinda Gooderham; Bruce Strober; Richard G. Langley; Carle Paul; Dirk De Cuyper; Veerle Vanvoorden; Cynthia Madden; Christopher Cioffi; Luke Peterson; Andrew Blauvelt

doi:10.1056/NEJMoa2102383

Bimekizumab versus Secukinumab in Plaque Psoriasis

Kristian Reich, Richard B. Warren, Mark Lebwohl, Melinda Gooderham, Bruce Strober, Richard G. Langley, Carle Paul, Dirk De Cuyper, Veerle Vanvoorden, Cynthia Madden, Christopher Cioffi, Luke Peterson, Andrew Blauvelt

Inernational Relations Division

科研成果: 期刊稿件 › 文章 › 同行评审

236 引用（Scopus）

源语言	英语
页（从-至）	142-152
页数	11
期刊	New England Journal of Medicine
卷	385
期	2
DOI	https://doi.org/10.1056/NEJMoa2102383
出版状态	已出版 - 7月 8 2021

!!!ASJC Scopus Subject Areas

一般医学

访问文件

10.1056/NEJMoa2102383

其它文件与链接

引用此

@article{40f7e9df1ed44dac96d8f53f4b0e7e5a,

title = "Bimekizumab versus Secukinumab in Plaque Psoriasis",

author = "Kristian Reich and Warren, {Richard B.} and Mark Lebwohl and Melinda Gooderham and Bruce Strober and Langley, {Richard G.} and Carle Paul and {De Cuyper}, Dirk and Veerle Vanvoorden and Cynthia Madden and Christopher Cioffi and Luke Peterson and Andrew Blauvelt",

year = "2021",

month = jul,

day = "8",

doi = "10.1056/NEJMoa2102383",

language = "English",

volume = "385",

pages = "142--152",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "2",

}

TY - JOUR

T1 - Bimekizumab versus Secukinumab in Plaque Psoriasis

AU - Reich, Kristian

AU - Warren, Richard B.

AU - Lebwohl, Mark

AU - Gooderham, Melinda

AU - Strober, Bruce

AU - Langley, Richard G.

AU - Paul, Carle

AU - De Cuyper, Dirk

AU - Vanvoorden, Veerle

AU - Madden, Cynthia

AU - Cioffi, Christopher

AU - Peterson, Luke

AU - Blauvelt, Andrew

PY - 2021/7/8

Y1 - 2021/7/8

UR - http://www.scopus.com/inward/record.url?scp=85108295487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85108295487&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa2102383

DO - 10.1056/NEJMoa2102383

M3 - Article

C2 - 33891380

AN - SCOPUS:85108295487

SN - 0028-4793

VL - 385

SP - 142

EP - 152

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 2

ER -

Bimekizumab versus Secukinumab in Plaque Psoriasis

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此